Polpharma

Polpharma is a Polish pharmaceutical company group that manufactures and markets medicines, generics, and active pharmaceutical ingredients. Headquartered in Starogard Gdański, Poland, it is among the largest pharmaceutical groups in Poland and Central and Eastern Europe. The group operates manufacturing facilities in Poland and has commercial and distribution networks in multiple countries. Its product portfolio includes generics, branded medicines, and contract manufacturing services for third parties.

The company traces its origins to the pre-war Polish pharmaceutical industry and has undergone several restructurings through the late 20th century, including privatization and modernization. It has expanded its reach through acquisitions and partnerships and has established subsidiaries focused on development, production, and distribution.

Polpharma emphasizes quality and regulatory compliance, with production aligned to EU good manufacturing practice standards. The company conducts research and development activities, including collaborations with academic and research institutions, and provides contract manufacturing and development services to other pharmaceutical firms.

In the international arena, Polpharma serves markets across Europe, Asia, Africa, and the Americas through its sales networks and distributors, supported by export-oriented manufacturing and regulatory affairs teams.